Literature DB >> 2085139

Inhibition of chemiluminescence in granulocytes and alveolar macrophages by azelastine.

J Schmidt1, B Kaufmann, R Lindstaedt, I Szelenyi.   

Abstract

The effect of azelastine, an orally effective antiasthmatic antiallergic drug on the generation of oxygen-derived free radicals in phagocytes was investigated using different chemiluminescence-assays. The chemiluminescence (CL) of both human polymorphonuclear granulocytes (PMNL) and guinea-pig alveolar macrophages (AM) was induced either by phorbol myristate acetate (PMA) or zymosan and amplified either by lucigenin or DMNH (7-dimethylamino-naphthalene-1,2-dicarbonic-acidhydrazide). The inhibitory effect of azelastine was dependent on the inducer employed and the condition and type of cells used. Azelastine reduced PMA-induced CL concentration-dependently in both PMNL (IC30 = 3.9 microM) and AM (IC30 = 9.8 microM). In AM zymosan-induced CL was inhibited 21.7% by 10 microM azelastine, whereas in PMNL it remained unchanged up to 10 microM azelastine. Azelastine has a significantly stronger inhibitory effect (IC30 = 4.2 microM) on oxygen free radical generation in AM primed by fetal calf serum than in unprimed AM. Based on present results it is likely that azelastine inhibits oxygen-derived free radical generation by interaction with protein kinase C.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2085139     DOI: 10.1007/BF01997613

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  29 in total

Review 1.  Receptor-mediated signal transduction in mononuclear phagocytes.

Authors:  D W Riches; J Y Channon; C C Leslie; P M Henson
Journal:  Prog Allergy       Date:  1988

Review 2.  The O2- -forming NADPH oxidase of the phagocytes: nature, mechanisms of activation and function.

Authors:  F Rossi
Journal:  Biochim Biophys Acta       Date:  1986-11-04

3.  Enhanced alveolar cell luminol-dependent chemiluminescence in asthma.

Authors:  M Cluzel; M Damon; P Chanez; J Bousquet; A Crastes de Paulet; F B Michel; P Godard
Journal:  J Allergy Clin Immunol       Date:  1987-08       Impact factor: 10.793

4.  The roles of extracellular and intracellular calcium in lysosomal enzyme release and superoxide anion generation by human neutrophils.

Authors:  J E Smolen; H M Korchak; G Weissmann
Journal:  Biochim Biophys Acta       Date:  1981-11-05

5.  Lucigenin chemiluminescence in the assessment of neutrophil superoxide production.

Authors:  H Gyllenhammar
Journal:  J Immunol Methods       Date:  1987-03-12       Impact factor: 2.303

6.  Lucigenin-dependent chemiluminescence as a new assay for NAD(P)H-oxidase activity in particulate fractions of human polymorphonuclear leukocytes.

Authors:  I Minkenberg; E Ferber
Journal:  J Immunol Methods       Date:  1984-06-08       Impact factor: 2.303

7.  Phorbol 12-myristate 13-acetate activates rabbit neutrophils without an apparent rise in the level of intracellular free calcium.

Authors:  R I Sha'afi; J R White; T F Molski; J Shefcyk; M Volpi; P H Naccache; M B Feinstein
Journal:  Biochem Biophys Res Commun       Date:  1983-07-29       Impact factor: 3.575

8.  Comparison between luminol- and lucigenindependent chemiluminescence of polymorphonuclear leukocytes.

Authors:  H Aniansson; O Stendahl; C Dahlgren
Journal:  Acta Pathol Microbiol Immunol Scand C       Date:  1984-12

9.  Recombinant interleukin 1 alpha and beta prime human monocyte superoxide production but have no effect on chemotaxis and oxidative burst response of neutrophils.

Authors:  A Kharazmi; H Nielsen; K Bendtzen
Journal:  Immunobiology       Date:  1988-04       Impact factor: 3.144

10.  Oxidative responses of rabbit alveolar macrophages: comparative priming activities of MIF/MAF, sera, and serum components.

Authors:  H Hayakawa; K Umehara; Q N Myrvik
Journal:  J Leukoc Biol       Date:  1989-03       Impact factor: 4.962

View more
  1 in total

1.  Influence of azelastine and some selected drugs on mucociliary clearance.

Authors:  U Achterrath-Tuckermann; V Saano; E Minker; F Stroman; I Arny; S Joki; J Nuutinen; I Szelenyi
Journal:  Lung       Date:  1992       Impact factor: 2.584

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.